Insider Selling: Exponent, Inc. (EXPO) CEO Sells 5,000 Shares of Stock
Exponent, Inc. (NASDAQ:EXPO) CEO Paul R. Johnston sold 5,000 shares of the business’s stock in a transaction on Monday, August 14th. The shares were sold at an average price of $65.28, for a total transaction of $326,400.00. Following the sale, the chief executive officer now directly owns 66,335 shares in the company, valued at $4,330,348.80. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Exponent, Inc. (NASDAQ EXPO) traded down 0.23% during trading on Wednesday, hitting $64.95. 45,814 shares of the stock were exchanged. The firm has a market capitalization of $1.68 billion, a PE ratio of 33.67 and a beta of 0.62. Exponent, Inc. has a 12-month low of $48.42 and a 12-month high of $68.30. The stock has a 50 day moving average price of $62.39 and a 200-day moving average price of $60.00.
Exponent (NASDAQ:EXPO) last posted its quarterly earnings data on Tuesday, July 18th. The business services provider reported $0.51 EPS for the quarter, beating the consensus estimate of $0.41 by $0.10. The business had revenue of $84.10 million for the quarter, compared to analysts’ expectations of $79.30 million. Exponent had a net margin of 15.94% and a return on equity of 16.52%. The firm’s revenue was up 14.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.38 EPS. On average, equities research analysts anticipate that Exponent, Inc. will post $1.97 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 22nd. Investors of record on Friday, September 1st will be given a $0.21 dividend. The ex-dividend date is Wednesday, August 30th. This represents a $0.84 annualized dividend and a yield of 1.29%. Exponent’s dividend payout ratio is currently 43.52%.
Several analysts have issued reports on EXPO shares. Cantor Fitzgerald reissued an “overweight” rating and set a $69.00 target price (up from $64.00) on shares of Exponent in a research note on Saturday, April 22nd. BidaskClub downgraded shares of Exponent from a “sell” rating to a “strong sell” rating in a research note on Tuesday, June 27th. Zacks Investment Research downgraded shares of Exponent from a “buy” rating to a “hold” rating in a research note on Friday, June 30th. Finally, ValuEngine raised shares of Exponent from a “sell” rating to a “hold” rating in a research note on Thursday, July 20th.
A number of large investors have recently bought and sold shares of EXPO. BlackRock Inc. boosted its stake in Exponent by 41,234.4% in the first quarter. BlackRock Inc. now owns 3,080,242 shares of the business services provider’s stock valued at $183,428,000 after buying an additional 3,072,790 shares in the last quarter. Norges Bank bought a new stake in Exponent during the fourth quarter valued at approximately $14,612,000. Renaissance Technologies LLC boosted its stake in Exponent by 43.8% in the second quarter. Renaissance Technologies LLC now owns 530,700 shares of the business services provider’s stock valued at $30,940,000 after buying an additional 161,600 shares in the last quarter. Voya Investment Management LLC boosted its stake in Exponent by 38.6% in the second quarter. Voya Investment Management LLC now owns 420,597 shares of the business services provider’s stock valued at $24,521,000 after buying an additional 117,147 shares in the last quarter. Finally, Schroder Investment Management Group bought a new stake in Exponent during the first quarter valued at approximately $6,312,000. 90.37% of the stock is currently owned by institutional investors and hedge funds.
Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.
Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.